HQH vs. ARCC

In the year-to-date period, HQH achieves a 0.79% return, which is significantly lower than ARCC's 2.38% return. Over the past 10 years, HQH has underperformed ARCC with an annualized return of 1.07%, while ARCC has yielded a comparatively higher 13.19% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Tekla Healthcare Investors (HQH) and Ares Capital Corporation (ARCC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current HQH Sharpe Ratio is 0.10, which is lower than the ARCC Sharpe Ratio of 0.65. The chart below compares the historical Sharpe Ratios of HQH and ARCC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

HQH's dividend yield for the trailing twelve months is around 15.12%, more than ARCC's 8.76% yield.

The maximum HQH drawdown since its inception was -56.17%, smaller than the maximum ARCC drawdown of -79.40%. Use the drawdown chart below to compare losses from any high point for HQH and ARCC. For additional features, visit the drawdowns tool.

Tekla Healthcare Investors (HQH) has a higher volatility of 8.26% compared to Ares Capital Corporation (ARCC) at 6.84%. This indicates that HQH's price experiences larger fluctuations and is considered to be riskier than ARCC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Tekla Healthcare Investors and Ares Capital Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.